FORT LAUDERDALE, FL - May 18, 2026 - PRESSADVANTAGE - A newly released educational resource from Grace Point Treatment ...
Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most ...
As weight-loss drugs like Ozempic revolutionize weight loss, scientists hope they may also be life-changing for alcohol addiction. The drugs are one of several approaches doctors and psychiatrists ...
Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to ...
GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, ...
Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...
Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially ...
Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 deaths each year and imposing an estimated $249 billion economic burden ...
I was addicted to alcohol for more than 15 years. What started as binge drinking in high school and college became a pattern of blackouts, emergency room visits, regret and shame. As peers grew up and ...
Two new clinical trials highlight potential breakthroughs in addiction medicine: semaglutide significantly reduced alcohol intake in patients with obesity and alcohol use disorder, while mirtazapine ...
Naloxone (Narcan), naltrexone (Trexan; ReVia), and Vivitrol (long-acting injectable naltrexone) changed addiction medicine into a profession with FDA-approved treatments for opioid overdose reversal, ...
Weight loss drugs such as Ozempic and Wegovy are enormously popular for people with diabetes, obesity and cardiovascular risk. So, health professionals wondered: Could these drugs also be the key to ...